Evaluation of 99mTc-Sestamibi as a potential tool to investigate PgP activity in inflammation by Costa, Pedro et al.
 
  
  
  
 
 
Evaluation of 
99m
Tc-Sestamibi as a potential tool to investigate Pgp 
activity in inflammation 
Costa, P
1
., Cunha, L.
1
, Alves, J.
 2
, Bravo, J.
 2
, Summavielle, T.
 2
, Metello, L.F.
1 
1- Nuclear Medicine Course of High Institute for Allied Health Technologies of Porto, Polytechnic Institute of Porto (ESTSP.IPP) 
2 - Neurobehaviour Unit - Institute of Molecular and Cell Biology of University of Porto. 
 
Introduction: In the XXI Century’s Society the scientific investigation process has 
been growing steadily, and the field of the pharmaceutical research is one of the most 
enthusiastic and relevant. Here, it is very important to correlate observed functional 
alterations with possibly modified drug biodistribution patterns. 
Cancer, inflammation and infection are processes that induce many molecular 
intermediates like cytokines, chemokines and other chemical complexes that can alter 
the pharmacokinetics of many drugs. One cause of such changes is thought to be the 
modulator action of these complexes in the P-Glycoprotein activity, because they can 
act like inducers/inhibitors of MDR-1 expression. This protein results from the 
expression of MDR-1 gene, and acts as an ATP energy-dependent efflux pump, with 
their substrates including many drugs, like antiretrovirals, anticancers, anti-infectives, 
immunosuppressants, steroids or opioids.  
Objectives: Because of the lack of methods to provide helpful information in the 
investigation of in vivo molecular changes in Pgp activity during infection/inflammation 
processes, and its value in the explanation of the altered drug pharmacokinetic, this 
paper want to evaluate the potential utility of 
99m
Tc-Sestamibi scintigraphy during this 
kind of health sciences investigation. Although the aim is indeed to create a technique to 
the in vivo study of Pgp activity, this preliminary Project only reaches the in vitro study 
phase, assumed as the first step in an evaluation period for a new tool development. 
Materials and Methods: For that reason, we are performing in vitro studies of influx 
and efflux of 
99m
Tc-Sestamibi (that is a substrate of Pgp) in hepatocytes cell line 
(HepG2). We are interested in clarify the cellular behavior of this radiopharmaceutical 
in Lipopolysaccharide(LPS) stimulated cells (well known in vitro model of 
inflammation) to possibly approve this methodology. To validate the results, the Pgp 
expression will be finally evaluated using Western Blot technique. 
 Results: Up to this moment, we still don’t have the final results, but we have already 
enough data to let us believe that LPS stimulation induce a downregulation of MDR-1, 
and consequently Pgp, which could conduce to a prolonged retention of 
99m
Tc-
Sestamibi in the inflamed cells.  
Conclusions: If and when this methodology demonstrate the promising results we 
expect, one will be able to conclude that Nuclear Medicine is an important tool to help 
evidence based research also on this specific field. 
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